title: Effect of budesonide and salbutamol on surfactant properties.
abstract: The objective of this study was to evaluate the in vitro effect of budesonide and salbutamol on the surfactant biophysical properties. The surface-tension properties of two bovine lipid extracts [bovine lipid extract surfactant (BLES) and Survanta] and a rat lung lavage natural surfactant were evaluated in vitro by the captive bubble surfactometer. Measurements were obtained before and after the addition of a low and high concentration of budesonide and salbutamol. Whereas salbutamol had no significant effect, budesonide markedly reduced the surface-tension-lowering properties of all surfactant preparations. Surfactant adsorption (decrease in surface tension vs. time) was significantly reduced (P < 0.01) at a high budesonide concentration with BLES, both concentrations with Survanta, and a low concentration with natural surfactant. At both concentrations, budesonide reduced (P < 0.01) Survanta film stability (minimal surface vs. time at minimum bubble volume), whereas no changes were seen with BLES. The minimal surface tension obtained for all surfactant preparations was significantly higher (P < 0.01), and the percentage of film area compression required to reach minimum surface tension was significantly lower after the addition of budesonide. In conclusion, budesonide, at concentrations used therapeutically, adversely affects the surface-tension-lowering properties of surfactant. We speculate that it may have the same adverse effect on the human surfactant.
authors.affiliation: Respiratory Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Palmer
authors.forename: S
authors.initials: S
authors.lastname: Schürch
authors.forename: J
authors.initials: J
authors.lastname: Belik
mesh_terms: D000287:Administration, Topical; D000327:Adsorption; D000420:Albuterol / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001688:Biological Products; D001993:Bronchodilator Agents / Q000494:pharmacology*; D019819:Budesonide / Q000494:pharmacology*; D005260:Female; D005938:Glucocorticoids; D008297:Male; D009994:Osmolar Concentration; D011663:Pulmonary Surfactants / Q000187:drug effects* / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013500:Surface Tension / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; D001688:Biological Products; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D011663:Pulmonary Surfactants; D019819:Budesonide; D000420:Albuterol; C072197:beractant